| The urgent need for microbiology literacy in society K Timmis, R Cavicchioli, JL Garcia, B Nogales, M Chavarría, L Stein, ... Environmental microbiology 21 (5), 1513-1528, 2019 | 149 | 2019 |
| The contribution of microbial biotechnology to sustainable development goals K Timmis, WM De Vos, JL Ramos, SE Vlaeminck, A Prieto, A Danchin, ... Microbial biotechnology 10 (5), 984-987, 2017 | 100 | 2017 |
| The contribution of microbial biotechnology to economic growth and employment creation K Timmis, V De Lorenzo, W Verstraete, JL Ramos, A Danchin, H Brüssow, ... Microbial biotechnology 10 (5), 1137, 2017 | 43 | 2017 |
| The DIY digital medical centre JK Timmis, K Timmis Microbial biotechnology 10 (5), 1084-1093, 2017 | 26 | 2017 |
| Synthetic consortia of nanobody‐coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis‐associated diseases and co‐morbidities K Timmis, JK Timmis, H Brüssow, LÁ Fernández Microbial biotechnology 12 (1), 58, 2019 | 25 | 2019 |
| The urgent need for microbiology literacy in society: children as educators K Timmis, J Timmis, F Jebok Microbial Biotechnology 13 (5), 1300-1303, 2020 | 22 | 2020 |
| Weaponising microbes for peace S Anand, JE Hallsworth, J Timmis, W Verstraete, A Casadevall, JL Ramos, ... Microbial Biotechnology 16 (6), 1091-1111, 2023 | 21 | 2023 |
| Pipelines for New Chemicals: a strategy to create new value chains and stimulate innovation‐based economic revival in Southern European countries K Timmis, V de Lorenzo, W Verstraete, JL Garcia, JL Ramos, H Santos, ... Environmental Microbiology 16 (1), 9-18, 2014 | 18 | 2014 |
| Stakeholder perspectives on barriers and facilitators for the adoption of virtual clinical trials: qualitative study RMH Coert, JK Timmis, A Boorsma, WJ Pasman Journal of medical Internet research 23 (7), e26813, 2021 | 17 | 2021 |
| Core values for vaccine evaluation JK Timmis, F Rigat, R Rappuoli Vaccine 35, A57-A62, 2017 | 14 | 2017 |
| The contribution of microbial biotechnology to sustainable development goals. Microb Biotechnol 10: 984–987 K Timmis, WM de Vos, JL Ramos, SE Vlaeminck, A Prieto, A Danchin, ... | 12 | 2017 |
| Improving accountability in vaccine decision-making JK Timmis, S Black, R Rappuoli Expert Review of Vaccines 16 (11), 1057-1066, 2017 | 11 | 2017 |
| Patent landscape analysis—Contributing to the identification of technology trends and informing research and innovation funding policy T van Rijn, JK Timmis Microbial Biotechnology 16 (4), 683-696, 2023 | 6 | 2023 |
| Left–Right‐Position, party affiliation and regional differences explain low COVID‐19 vaccination rates in Germany S Jäckle, JK Timmis Microbial Biotechnology 16 (3), 662-677, 2023 | 5 | 2023 |
| Strategies to minimize preventable morbidity and mortality resulting from pandemics like COVID-19 K Timmis, WE Huang, J Timmis Environmental Microbiology 22 (10), 2020 | 4 | 2020 |
| Microbiome yarns: microbiomology of curly and straight hair K Timmis, F Jebok, F Rigat, W M. de Vos, JK Timmis Microbial Biotechnology 10 (2), 231-237, 2017 | 4 | 2017 |
| A routine check‐up at the digital medical centre KN Timmis, JK Timmis Microbial Biotechnology 10 (1), 25, 2017 | 4 | 2017 |
| Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives A Dane, S Ashraf, J Timmis, M Bos, C Uyl-de Groot, PHM van der Kuy BMJ open 12 (2), e055165, 2022 | 3 | 2022 |
| Market knowledge and stakeholder considerations for the biopharmaceutics sector—incorporating user value and societal needs in therapeutic interventions JK Timmis, RX Van Der Waal, J Herz, MB Van Der Waal, E Claassen, ... | 3 | 2021 |
| A concept for international societally relevant microbiology education and microbiology knowledge promulgation in society K Timmis, JE Hallsworth, TJ McGenity, R Armstrong, MF Colom, ... Microbial biotechnology 17 (5), e14456, 2024 | 2 | 2024 |
